Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease

Nature Clinical Practice Neurology

Volumn 2, Issue 11, 2006, Pages 578-579

  Rabins, Peter V ^a   Lyketsos, Constantine G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTINEOPLASTIC AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; MEMANTINE; RILUZOLE; RIVASTIGMINE;

ADVANCED CANCER; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; COGNITIVE DEFECT; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DRUG APPROVAL; DRUG CHOICE; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RETREATMENT; REVIEW; RISK BENEFIT ANALYSIS; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MEMANTINE;

EID: 33750321420     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0269     Document Type: Review

References (10)

1. Kaduszkiewicz H et al. (2005) Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomized clinical trials. BMJ 331: 321-327
2. McShane R and Schneider L (2005) Meta-analysis of memantine: Summary and commentary on the Cochrane Collaboration's systematic review. Alzheimer's and Dementia 1: 67-71
3. Doody RS et al. (2001) Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1154-1166
4. American Psychiatric Association: Treatment Guideline: Alzheimer's disease and other dementias of late life. Am J Psychiatry, in press
5. Peterson R et al. (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352: 1-10
6. Trinh N et al. (2003) Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: A meta-analysis. JAMA 289: 210-216
7. Rabins P et al. (1982) The impact of dementia on the family. JAMA 248: 333-335
8. Lyketsos CG et al. (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment. JAMA 288: 1475-1483
9. Winblad B et al. (2006) Donepezil in patients with severe Alzheimer's disease: Double-blind, parallel-group, placebo-controlled study. Lancet 367: 1057-1065.
10. Rabins P et al. (2006) Practical Dementia Care. Oxford and New York: Oxford University Press